Rein Therapeutics
$0.9157
39
+$0.05+5.87% Thursday 20:00
Statistics
Day High
0.93
Day Low
0.865
52W High
2.18
52W Low
0.864
Volume
2,056,700
Avg. Volume
-
Mkt Cap
24.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12AugExpected
Expected EPS
-0.27
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-125.77MNet Income
Analyst Ratings
8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RNTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Kura Oncology
KURA
Mkt Cap803.41M
Agios Pharmaceuticals
AGIO
Mkt Cap1.75B
Incyte
INCY
Mkt Cap21.68B
Exelixis
EXEL
Mkt Cap13.35B
Array Technologies
ARRY
Mkt Cap1.2B
Novartis
NVS
Mkt Cap292.07B
About
Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky, and its main corporate offices are situated in Austin, Texas.
Show more...
CEO
Dr. Cory M. Hogaboam Ph.D.
Employees
11
Country
United States
ISIN
US00887A2042
Listings
0 Comments
Share your thoughts
FAQ
What is Rein Therapeutics stock price today?▼
The current price of RNTX is $0.92 USD — it has increased by +5.87% in the past 24 hours. Watch Rein Therapeutics stock price performance more closely on the chart.
What is Rein Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rein Therapeutics stocks are traded under the ticker RNTX.
Is Rein Therapeutics stock price growing?▼
RNTX stock has fallen by -4.41% compared to the previous week, the month change is a -7.97% fall, over the last year Rein Therapeutics has showed a -40.54% decrease.
What is Rein Therapeutics market cap?▼
Today Rein Therapeutics has the market capitalization of 24.07M
When is the next Rein Therapeutics earnings date?▼
Rein Therapeutics is going to release the next earnings report on August 12, 2026.
What were Rein Therapeutics earnings last quarter?▼
RNTX earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.49 USD resulting in a +61.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rein Therapeutics revenue for the last year?▼
Rein Therapeutics revenue for the last year amounts to 0 USD.
What is Rein Therapeutics net income for the last year?▼
RNTX net income for the last year is -125.77M USD.
How many employees does Rein Therapeutics have?▼
As of June 20, 2026, the company has 11 employees.
In which sector is Rein Therapeutics located?▼
Rein Therapeutics operates in the Health & Wellness sector.
When did Rein Therapeutics complete a stock split?▼
The last stock split for Rein Therapeutics was on November 11, 2022 with a ratio of 1:20.
Where is Rein Therapeutics headquartered?▼
Rein Therapeutics is headquartered in Austin, United States.